MOS
TMDX icon

MGO One Seven’s Transmedics TMDX Stock Holding History

MGO One Seven’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,357
Closed -$269K – 897
2022
Q4 		$269K Sell
4,357
-19,257
-82% -$1.02M 0.03% 588
2022
Q3 		$985K Buy
+23,614
New +$1.03M 0.04% 249

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return

MGO One Seven's TMDX Position: Q1 2023 in Review

MGO One Seven sold out of Transmedics (TMDX) in Q1 2023, closing a stake of 4,357 shares — an estimated $269K sold.

MGO One Seven first reported a position in TMDX in Q3 2022 and held it in 2 quarters. The position peaked at $985K in Q3 2022. 224 funds tracked by Wall St. Rank hold TMDX as of Q1 2023.

  • MGO One Seven reported no remaining Transmedics position as of Q1 2023 after selling out during the quarter.
  • MGO One Seven sold 4,357 Transmedics shares in Q1 2023, an estimated $269K.
  • MGO One Seven first reported a position in Transmedics in Q3 2022 and held it in 2 quarters.
  • MGO One Seven's Transmedics position peaked at $985K in Q3 2022.
  • 224 funds tracked by Wall St. Rank held Transmedics as of Q1 2023.

Based on MGO One Seven's 13F filing for Q1 2023, filed 8 May 2023.